Keyword: oncology

News

GSK Outlines Pipeline for Next 10 Years

06.11.2015 - GlaxoSmithKline (GSK) is expecting to file 20 new drugs by 2020, with another 20 to follow in the following five years. In a presentation to investors in New York, CEO Andrew Witty...

News

Sanofi and BioNTech Collaborate on Cancer

05.11.2015 - French pharmaceutical producer Sanofi and German biotech firm BioNTech have agreed a multi-year exclusive collaboration and license agreement aimed at leveraging their respective...

Markets & Companies

Leaving the Patent Cliff Behind

07.10.2015 - The pharmaceutical industry is entering a period of sustained growth. Prescription drug sales are set to advance at almost 5% a year until 2020, while worldwide prescription drug...

News

Starpharma in Drug Delivery Pact with AstraZeneca

09.09.2015 - Australia’s Starpharma has signed a licensing agreement with AstraZeneca, giving the Anglo-Swedish company commercialization rights for oncology compounds directed at a defined...

News

AbbVie Completes Pharmacyclics Acquisition

28.05.2015 - AbbVie has completed the acquisition of Pharmacyclics, a deal the Chicago-based US drugmaker says enhances its scientific and commercial presence in oncology. As a wholly owned...

News

Novartis Gets Green Light to Buy GSK Cancer Drugs

27.02.2015 - The U.S. Federal Trade Commission has granted Novartis permission to acquire the GlaxoSmithKline (GSK) oncology portfolio - with some strings attached. Canada's competition...

News

Qiagen and Astellas Pharma to Develop Companion Diagnostics

03.11.2014 - Dutch genetic testing specialist Qiagen has signed a master collaboration agreement with Astellas Pharma, a Japanese R&D-driven global pharmaceutical company, to develop and...

News

Crown Bioscience Opens Oncology Center in North Carolina

24.10.2014 - US drug discovery and development service provider Crown Bioscience has opened a new research center at Kannapolis, North Carolina. The new center, which Crown said represents a...